Prostatitis
From Anvita Health Wiki
Contents |
Introduction
- Inflammation/infection of the prostate gland. A common cause of urinary tract infection ( UTI) in men.
Etiology
- mechanisms
- ascending urethral infection
- reflux of infected urine
- contiguous spread from rectum
- hematogenous spread
- idiopathic (chronic prostatitis/pelvic pain syndrome) [4]
Epidemiology
- acute prostatitis is uncommon
- chronic prostatitis is more common
Pathology
- repeated urinary tract infections caused by the same pathogen
- antimicrobial agents diffuse poorly into the prostate
- pain does not correlated with histological inflammation [5]
- some evidence for neuropathic pain [7]
Clinical-manifestations
- constitutional:
- oliguria, dysuria, nocturia, hesitancy, dribbling
- prostate tenderness, enlargement, bogginess on rectal exam
- bladder distention ( suprapubic pressure)
- peritoneal & back pain (acute)
- rectal pressure
- sexual dysfunction
Laboratory
- urinalysis
- expressed prostatic secretions
Differential-diagnosis
Management
- IV therapy, hospitalized patients with acute prostatitis
- ampicillin plus aminoglycoside
- cephalosporin plus aminoglycoside
- oral therapy for 3-4 weeks [1] (4 weeks [2])
- Bactrim DS BID
- ampicillin 500 mg QID
- tetracycline 500 mg QID
- doxycycline 100 mg BID
- carbenicillin 1 g QID
- ciprofloxacin 500 mg BID
- treat benign prostatic hyperplasia [6]
- patient education
- discontinue over-the-counter decongestants
- sitz baths may help difficulty voiding
- diet
- avoid spicy foods if they cause exacerbation of symptoms
- avoid caffeine
- activity: no restrictions
- follow-up
- acute prostatitis: re-evaluation 48-72 hours
- chronic prostatitis:
- within 2-3 weeks & 1 month after completion of antibiotics
- pharmacotherapy not helpful [4]
- referral to urologist if indicated
More General Terms
Additional Terms
References
- Saunders Manual of Medical Practice, Rakel (ed), WB Saunders, Philadelphia, 1996, pg 554-55
- UCLA Intensive Course in Geriatric Medicine & Board Review, Marina Del Ray, CA, Sept 12-15, 2001
- Roberts & Leiber 49:809, 1997
- Journal Watch 24(23):173, 2004 Alexander RB, Propert KJ, Schaeffer AJ, Landis JR, Nickel JC, O'Leary MP, Pontari MA, McNaughton-Collins M, Shoskes DA, Comiter CV, Datta NS, Fowler JE Jr, Nadler RB, Zeitlin SI, Knauss JS, Wang Y, Kusek JW, Nyberg LM Jr, Litwin MS; Chronic Prostatitis Collaborative Research Network. Ciprofloxacin or tamsulosin in men with chronic prostatitis/chronic pelvic pain syndrome: a randomized, double-blind trial. Ann Intern Med. 2004 Oct 19;141(8):581-9. PMID: [1]
- Nickel JC et al, Examination of the relationship between symptoms of prostatitis and histological inflammation: Basline data from the REDUCE chemoprevention trial. J Urol 2007, 178:896 PMID: [2]
- Medical Knowledge Self Assessment Program (MKSAP) 15, American College of Physicians, Philadelphia 2009
- Pontari MA et al. Pregabalin for the treatment of men with chronic prostatitis/chronic pelvic pain syndrome: A randomized controlled trial. Arch Intern Med 2010 Sep 27; 170:1586. PMID: &dopt=Abstract
- Prostatitis: Disorders of the Prostate [3]
- Chronic Prostatitis Workshop [4] - National Guideline Clearinghouse United Kingdom national guideline for the management of prostatitis British Association for Sexual Health and HIV ngc-guideline: [5]
- Prostatitis and chronic pelvic pain syndrome. In: Guidelines on the management of urinary and male genital tract infections. European Association of Urology ngc-guideline: [6]
